The Metabolic Syndrome Institute Literature Watch features
the latest articles on the metabolic syndrome.
Click on the links below to view the abstracts for each article.

Adiponectin

  • Further inflammatory information on metabolic syndrome by adiponectin evaluation.
    (Matsushita K, et.al. Int J Cardiol. 2008 Mar 14;124(3):339-44. Epub 2007 Apr 11.)
    View Abstract
  • The pro-inflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin.
    (Natal C, et.al. J Clin Endocrinol Metab. 2008 Mar 18; [Epub ahead of print])
    View Abstract
  • Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome.
    (Selcuk MT, et.al. Coron Artery Dis. 2008 Mar;19(2):79-84.)
    View Abstract
  • Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study.
    (Tabara Y, et.al. J Clin Endocrinol Metab. 2008 Mar;93(3):715-22. Epub 2007 Dec 26.)
    View Abstract
  • A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks.
    (Tsuda S, et.al. Diabetes Res Clin Pract. 2008 Mar;79(3):503-9. Epub 2007 Nov 19.)
    View Abstract

Apo / Lipoproteins

  • Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
    (Sjögren P, et.al. Metabolism. 2008 Mar;57(3):362-6.)
    View Abstract
  • Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity.
    (de Souza JA, et.al. Atherosclerosis. 2008 Mar;197(1):84-94. Epub 2007 Sep 14.)
    View Abstract
  • Apolipoprotein B is a better marker than non-HDL-cholesterol for the metabolic syndrome in Koreans.
    (Han JH, et.al. Atherosclerosis. 2008 Mar;197(1):333-8. Epub 2007 Jul 12.)
    View Abstract
  • Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: The GOCADAN study.
    (Rivellese AA, et.al. Atherosclerosis. 2008 Mar 29; [Epub ahead of print])
    View Abstract

Cancer

  • Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.
    (Smith MR, et.al. Cancer. 2008 Mar 17; [Epub ahead of print])
    View Abstract

Cardiovascular Disease

  • Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridemia with or without the metabolic syndrome.
    (Cardona F, et.al. Clin Biochem. 2008 Mar 13; [Epub ahead of print])
    View Abstract
  • The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population.
    (Noto D, et.al. Atherosclerosis. 2008 Mar;197(1):147-53. Epub 2007 Apr 26.)
    View Abstract
  • Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men.
    (Pischon T, et.al. Atherosclerosis. 2008 Mar;197(1):392-9. Epub 2007 Aug 2.)
    View Abstract
  • Metabolic syndrome does not impact survival in patients treated for coronary artery disease.
    (Shah B, et.al. Coron Artery Dis. 2008 Mar;19(2):71-7.)
    View Abstract
  • Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction.
    (Takeno M, et.al. Circ J. 2008 Mar;72(3):415-9.)
    View Abstract
  • Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis.
    (Zhong M, et.al. Clin Endocrinol (Oxf). 2008 Mar 20; [Epub ahead of print])
    View Abstract

Diabetes

  • The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
    (Alizadeh Dehnavi R, et.al. Eur J Intern Med. 2008 Mar;19(2):115-21. Epub 2007 Nov 5.)
    View Abstract
  • Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus.
    (Depaula AL, et.al. Surg Endosc. 2008 Mar 18; [Epub ahead of print])
    View Abstract
  • Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
    (Dullaart RP, et.al. Clin Endocrinol (Oxf). 2008 Mar;68(3):375-81. Epub 2007 Sep 18.)
    View Abstract
  • Metabolic syndrome and its components as predictors of ischemic stroke in type 2 diabetic patients.
    (Protopsaltis I, et.al. Stroke. 2008 Mar;39(3):1036-8. Epub 2008 Jan 31.)
    View Abstract
  • 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome.
    (Schnackenberg CG.Curr Opin Investig Drugs. 2008 Mar;9(3):295-300.)
    View Abstract
  • Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
    (Song SH, et.al. QJM. 2008 Mar 19; [Epub ahead of print])
    View Abstract

Diet, Nutrition and Metabolism

  • Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome.
    (Devaraj S, et.al. Free Radic Biol Med. 2008 Mar 15;44(6):1203-8. Epub 2007 Dec 23.)
    View Abstract
  • Cross-sectional relationship between dietary carbohydrate, glycaemic index, glycaemic load and risk of the metabolic syndrome in a Korean population.
    (Kim K, et.al. Br J Nutr. 2008 Mar 10;:1-9 [Epub ahead of print])
    View Abstract
  • Dietary fructose and the metabolic syndrome.
    (Miller A, et.al. Curr Opin Gastroenterol. 2008 Mar;24(2):204-9.)
    View Abstract

Drug Therapy

  • High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study.
    (Barrios V, et.al. Int J Clin Pract. 2008 Mar 17; [Epub ahead of print])
    View Abstract
  • Metformin, arterial function, intima-media thickness and nitrooxidation in metabolicsyndrome: The Mefisto study..
    (Meaney E, et.al. Clin Exp Pharmacol Physiol. 2008 Mar 12; [Epub ahead of print])
    View Abstract
  • Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.
    (Ooi EM, et.al. Atherosclerosis. 2008 Mar;197(1):139-46. Epub 2007 Apr 9.)
    View Abstract
  • Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.
    (Rosenson RS.Am Heart J. 2008 Mar;155(3):499.e9-16. Epub 2008 Jan 31.)
    View Abstract
  • Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome.
    (Vemuri VK, et.al. Physiol Behav. 2008 Mar 18;93(4-5):671-86. Epub 2007 Nov 21.)
    View Abstract

Epidemiology

  • Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study.
    (Erem C, et.al. Endocrine. 2008 Mar 13; [Epub ahead of print])
    View Abstract
  • The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome.
    (Firmann M, et.al. BMC Cardiovasc Disord. 2008 Mar 17;8(1):6 [Epub ahead of print])
    View Abstract
  • Metabolic syndrome and health-related quality of life among U.S. adults.
    (Ford ES, et.al. Ann Epidemiol. 2008 Mar;18(3):165-71.)
    View Abstract
  • Costs of metabolic syndrome-related diseases induced by obesity in Taiwan.
    (Fu T, et.al. Obes Rev. 2008 Mar;9 Suppl 1:68-73.)
    View Abstract
  • The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population--mainly a function of overweight?
    (Hollman G, et.al. Eur J Cardiovasc Nurs. 2008 Mar;7(1):21-6. Epub 2007 Jun 22.)
    View Abstract
  • The increasing prevalence of metabolic syndrome among Finnish men and women over a decade.
    (Hu G, et.al. J Clin Endocrinol Metab. 2008 Mar;93(3):832-6. Epub 2007 Dec 11.)
    View Abstract
  • All-cause and cardiovascular disease mortality increased with metabolic syndrome in Taiwanese.
    (Huang KC, et.al. Obesity (Silver Spring). 2008 Mar;16(3):684-9. Epub 2008 Jan 17.)
    View Abstract
  • Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes.
    (Iwasaki T, et.al. Diabetes Res Clin Pract. 2008 Mar;79(3):427-32. Epub 2008 Jan 22.)
    View Abstract
  • Metabolic syndrome and Framingham risk score for prediction of cardiovascular events in Caribbean Indian patients with blood glucose abnormalities.
    (Jaquet A, et.al. Diabetes Metab. 2008 Mar 17; [Epub ahead of print])
    View Abstract
  • Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population.
    (Lee MY, et.al. Diabet Med. 2008 Mar 13; [Epub ahead of print])
    View Abstract
  • Developmental origin of metabolic syndrome: interaction of thinness at birth and overweight during adult life in Chinese population.
    (Mi J, et.al. Obes Rev. 2008 Mar;9 Suppl 1:91-4.)
    View Abstract
  • Comparison of serum uric acid levels between Japanese with and without metabolic syndrome.
    (Numata T, et.al. Diabetes Res Clin Pract. 2008 Apr;80(1):e1-5. Epub 2008 Mar 7.)
    View Abstract
  • Prevalence of obesity and metabolic syndrome in Korean adults.
    (Park HS, et.al. Obes Rev. 2008 Mar;9(2):104-7. Epub 2007 Nov 6.)
    View Abstract
  • Distinct component profiles and high risk among African Americans with the metabolic syndrome: The Jackson Heart Study.
    (Taylor H, et.al. Diabetes Care. 2008 Mar 10; [Epub ahead of print])
    View Abstract
  • Prevalence of metabolic syndrome compared between native Japanese and Japanese-Americans.
    (Yoneda M, et.al. Diabetes Res Clin Pract. 2008 Mar;79(3):518-22. Epub 2007 Nov 19.)
    View Abstract

Exercise

  • Cardiorespiratory fitness as a feature of the metabolic syndrome in older men and women: The DR's EXTRA Study.
    (Hassinen M, et.al. Diabetes Care. 2008 Mar 10; [Epub ahead of print])
    View Abstract
  • Physical activity level and its association with metabolic syndrome among an employed population in China.
    (Ma G, et.al. Obes Rev. 2008 Mar;9 Suppl 1:113-8.)
    View Abstract

Genetics

  • Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample.
    (Al-Attar SA, et.al. Cardiovasc Diabetol. 2008 Mar 13;7:5.)
    View Abstract
  • Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    (Iwasaki Y, et.al. Mol Cell Endocrinol. 2008 Mar 26;285(1-2):10-8. Epub 2008 Feb 2.)
    View Abstract
  • Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.
    (Kilpeläinen TO, et.al. Metabolism. 2008 Mar;57(3):428-36.)
    View Abstract
  • Association of estrogen receptor-alpha gene polymorphisms with stroke risk in patients with metabolic syndrome.
    (Lazaros L, et.al. Acta Neurol Scand. 2008 Mar;117(3):186-90. Epub 2007 Sep 14.)
    View Abstract
  • Association between liver X receptor alpha gene polymorphisms and risk of metabolic syndrome in French populations.
    (Legry V, et.al. Int J Obes (Lond). 2008 Mar;32(3):421-8. Epub 2008 Jan 22.)
    View Abstract
  • Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
    (Lloyd DJ, et.al. Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E496-505. Epub 2007 Dec 26.)
    View Abstract

Hypertension

  • Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA Study.
    (Escobar C, et.al. J Clin Hypertens (Greenwich). 2008 Mar;10(3):208-14.)
    View Abstract
  • Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: A community-based study.
    (Hsu PF, et.al. Diabetes Res Clin Pract. 2008 Mar;79(3):461-7. Epub 2007 Nov 14.)
    View Abstract
  • The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome.
    (Leibowitz A, et.al. Am J Hypertens. 2008 Mar;21(3):348-51. Epub 2008 Jan 24.)
    View Abstract

Innovative Techniques / Modeling

  • Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA.
    (Stejskal D, et.al. Clin Biochem. 2008 Mar;41(4-5):313-6. Epub 2007 Nov 29.)
    View Abstract

Insulin Sensitivity / Insulin Resistance

  • Metabolic syndrome and insulin resistance: perioperative considerations.
    (Bagry HS, et.al. Anesthesiology. 2008 Mar;108(3):506-23. Review.)
    View Abstract
  • Impaired early insulin secretion in Japanese type 2 diabetes with metabolic syndrome.
    (Fukuda-Akita E, et.al. Diabetes Res Clin Pract. 2008 Mar;79(3):482-9. Epub 2007 Nov 14.)
    View Abstract

Kidney Disease

  • Is fetuin-A/alpha2-heremans-schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney Disease?
    (Axelsson J, et.al. Am J Nephrol. 2008 Mar 13;28(4):669-676 [Epub ahead of print])
    View Abstract
  • The conundrum of hyperuricemia, metabolic syndrome, and renal disease.
    (Nakagawa T, et.al. Intern Emerg Med. 2008 Mar 5; [Epub ahead of print])
    View Abstract
  • Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids.
    (Rike AH, et.al. Clin Transplant. 2008 Mar-Apr;22(2):229-35.)
    View Abstract

Lifestyle Interventions / Treatment

  • Lifestyle intervention in the management of metabolic syndrome: could we improve adherence issues?
    (Fappa E, et.al. Nutrition. 2008 Mar;24(3):286-91. Epub 2008 Jan 16.)
    View Abstract
  • Complementary and alternative medicine and the management of the metabolic syndrome.
    (Hollander JM, et.al. J Am Diet Assoc. 2008 Mar;108(3):495-509.)
    View Abstract
  • From a glucocentric to a lipocentric approach towards metabolic syndrome.
    (Mittra S, et.al. Drug Discov Today. 2008 Mar;13(5-6):211-8. Epub 2008 Mar 7.)
    View Abstract

Metabolic Syndrome in Women

  • Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    (Cheung LP, et.al. Hum Reprod. 2008 Mar 21; [Epub ahead of print])
    View Abstract
  • beta(3)-Adrenergic receptor polymorphism and metabolic syndrome in postmenopausal women.
    (Dunajska K, et.al. Gynecol Endocrinol. 2008 Mar;24(3):133-8.)
    View Abstract
  • Illustrating the roles of C-reactive protein in the development of the metabolic syndrome in women - a cross-racial validation.
    (Hwang JJ, et.al. Nutr Metab Cardiovasc Dis. 2008 Mar 29; [Epub ahead of print])
    View Abstract
  • Metabolic syndrome and the menopause.
    (Kaaja RJ.Menopause Int. 2008 Mar;14(1):21-5.)
    View Abstract
  • Intrauterine growth restriction in a rodent model and developmental programming of the metabolic syndrome: A critical appraisal of the experimental evidence.
    (Neitzke U, et.al. Placenta. 2008 Mar;29(3):246-254. Epub 2008 Jan 22.)
    View Abstract
  • Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife--SWAN, the study of women's health across the nation.
    (Ram KT, et.al. Am J Obstet Gynecol. 2008 Mar;198(3):268.e1-6. Epub 2008 Jan 14.)
    View Abstract
  • Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    (Soares EM, et.al. Fertil Steril. 2008 Mar;89(3):649-55. Epub 2007 Jun 4.)
    View Abstract
  • Gestational diabetes: The forerunner for the development of maternal and childhood obesity and metabolic syndrome?
    (Vohr BR, et.al. J Matern Fetal Neonatal Med. 2008 Mar;21(3):149-57.)
    View Abstract

Non-Alcholic Fatty Liver Disease

  • Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease.
    (Devers MC, et.al. Diabet Med. 2008 Mar 13; [Epub ahead of print])
    View Abstract
  • Metabolic Syndrome Is Related to Nonalcoholic Steatohepatitis in Severely Obese Subjects.
    (Huang HL, et.al. Obes Surg. 2008 Mar 12; [Epub ahead of print])
    View Abstract
  • Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    (Musso G, et.al. Diabetes Care. 2008 Mar;31(3):562-8. Epub 2007 Dec 4.)
    View Abstract

Obesity

  • The influence of age and body mass index on the metabolic syndrome and its components.
    (Alexander CM, et.al. Diabetes Obes Metab. 2008 Mar;10(3):246-50.)
    View Abstract
  • Abdominal obesity and the metabolic syndrome: Contribution to global cardiometabolic risk.
    (Després JP, et.al. Arterioscler Thromb Vasc Biol. 2008 Mar 20; [Epub ahead of print])
    View Abstract
  • Effect of a weight management program on the determinants and prevalence of metabolic syndrome.
    (La Londe MA, et.al. Obesity (Silver Spring). 2008 Mar;16(3):637-42. Epub 2008 Jan 17.)
    View Abstract
  • Factor analysis of metabolic syndrome components in obese women.
    (Lafortuna CL, et.al. Nutr Metab Cardiovasc Dis. 2008 Mar;18(3):233-41. Epub 2007 Jun 27.)
    View Abstract
  • Remission of metabolic syndrome: A study of 140 patients six months after Roux-en-Y gastric bypass.
    (Rossi M, et.al. Obes Surg. 2008 Mar 27; [Epub ahead of print])
    View Abstract
  • Skeletal muscle metabolic dysfunction in obesity and metabolic syndrome.
    (Wells GD, et.al. Can J Neurol Sci. 2008 Mar;35(1):31-40.)
    View Abstract

Pediatrics

  • Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation.
    (Ford ES, et.al. Diabetes Care. 2008 Mar;31(3):587-9. Epub 2007 Dec 10.)
    View Abstract
  • Prevalence of the metabolic syndrome in Chinese adolescents.
    (Li Y, et.al. Br J Nutr. 2008 Mar;99(3):565-70. Epub 2007 Jul 30.)
    View Abstract
  • Relationship between screen time and metabolic syndrome in adolescents.
    (Mark AE, et.al. J Public Health (Oxf). 2008 Mar 28; [Epub ahead of print])
    View Abstract
  • Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study.
    (Mattsson N, et.al. Eur Heart J. 2008 Mar;29(6):784-91. Epub 2007 Dec 15.)
    View Abstract
  • C-reactive protein and metabolic syndrome in youth: A strong relationship?
    (Oliveira AC, et.al. Obesity (Silver Spring). 2008 Mar 6; [Epub ahead of print])
    View Abstract
  • Elevated glucose concentrations during an oral glucose tolerance test are associated with the presence of metabolic syndrome in childhood obesity.
    (Sabin MA, et.al. Diabet Med. 2008 Mar;25(3):289-95.)
    View Abstract
  • Physical activity, cardio-respiratory fitness and the metabolic syndrome in youth.
    (Steele RM, et.al. J Appl Physiol. 2008 Mar 27; [Epub ahead of print])
    View Abstract
  • Prevalence of the metabolic syndrome in secondary school adolescents in Beijing, China.
    (Xu YQ, et.al. Acta Paediatr. 2008 Mar;97(3):348-53.)
    View Abstract

Psychiatric Disorders

  • Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: A cross-sectional assessment of a primary health care database.
    (Sicras-Mainar A, et.al. Eur Psychiatry. 2008 Mar;23(2):100-8. Epub 2007 Sep 29.)
    View Abstract
  • Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
    (van Winkel R, et.al. Bipolar Disord. 2008 Mar;10(2):342-8.)
    View Abstract

Risk Factors

  • Pre-morbid intelligence, the metabolic syndrome and mortality: the Vietnam Experience Study.
    (Batty GD, et.al. Diabetologia. 2008 Mar;51(3):436-43. Epub 2008 Jan 18.)
    View Abstract
  • Hyperuricemia, gout and the metabolic syndrome.
    (Puig JG, et.al. Curr Opin Rheumatol. 2008 Mar;20(2):187-91.)
    View Abstract
  • Metabolic syndrome and uric Acid nephrolithiasis.
    (Sakhaee K, et.al. Semin Nephrol. 2008 Mar;28(2):174-80.)
    View Abstract
  • Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study.
    (Watanabe H, et.al. Circulation. 2008 Mar 11;117(10):1255-60. Epub 2008 Feb 19.)
    View Abstract
  • Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen.
    (Yen SL, et.al. Int J Obes (Lond). 2008 Mar;32(3):474-80. Epub 2007 Oct 23.)
    View Abstract

Screening & Diagnosis

  • The relative value of metabolic syndrome and cardiovascular risk score estimates in premature acute coronary syndromes.
    (Kalantzi K, et.al. Am Heart J. 2008 Mar;155(3):534-40.)
    View Abstract
  • Metabolic syndrome in a large chemical company: prevalence in a screened worksite sample.
    (Oberlinner C, et.al. Acta Diabetol. 2008 Mar;45(1):31-5. Epub 2007 Sep 20.)
    View Abstract
  • Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome.
    (Oka R, et.al. Diabetes Res Clin Pract. 2008 Mar;79(3):474-81. Epub 2007 Nov 26.)
    View Abstract
  • Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population.
    (Strazzullo P, et.al. Metabolism. 2008 Mar;57(3):355-61.)
    View Abstract

Stroke

  • Metabolic syndrome Is associated with silent ischemic brain lesions.
    (Bokura H, et.al. Stroke. 2008 Mar 6; [Epub ahead of print])
    View Abstract
  • Association between metabolic syndrome and previous ischemic lesions in patients with intracranial atherosclerotic stroke.
    (Park JH, et.al. Clin Neurol Neurosurg. 2008 Mar;110(3):215-21. Epub 2007 Dec 4.)
    View Abstract
  • The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland.
    (Wang J, et.al. Stroke. 2008 Apr;39(4):1078-83. Epub 2008 Mar 6.)
    View Abstract

Vascular Biology

  • Atypical protein kinase C dysfunction and the metabolic syndrome.
    (Beguinot F, et.al. Trends Endocrinol Metab. 2008 Mar;19(2):39-41. Epub 2008 Feb 21.)
    View Abstract
  • Control of muscle mitochondria by insulin entails activation of Akt2-mtNOS pathway: implications for the metabolic syndrome.
    (Finocchietto P, et.al. PLoS ONE. 2008 Mar 12;3(3):e1749.)
    View Abstract
  • Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome.
    (Giral P, et.al. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):587-93. Epub 2008 Jan 17.)
    View Abstract
  • Determinants of endothelial function in asymptomatic subjects with and without the metabolic syndrome.
    (Melikian N, et.al. Atherosclerosis. 2008 Mar;197(1):375-82. Epub 2007 Jul 24.)
    View Abstract
  • Bioactive lipids in metabolic syndrome.
    (Nagao K, et.al. Prog Lipid Res. 2008 Mar;47(2):127-46. Epub 2007 Dec 15.)
    View Abstract

 

Coordinated by Dr. Scott Grundy, Past-President of the IAS